Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
08/03/2011 | EP2349266A1 Sulfonamide containing compounds and uses thereof |
08/03/2011 | EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators |
08/03/2011 | EP2348846A1 Disubstituted azepan orexin receptor antagonists |
08/03/2011 | EP2240458B1 Aryl sulfonamides as effective analgesics |
08/03/2011 | EP2155690B1 Indazolamide derivatives |
08/03/2011 | EP2152674B1 Benzimidazolone chymase inhibitors |
08/03/2011 | EP1794146B1 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
08/03/2011 | CN1964970B Iap的抑制剂 Iap inhibitors |
08/03/2011 | CN1890218B Tubulin inhibitors |
08/03/2011 | CN102143959A Hepatitis c virus inhibitors |
08/03/2011 | CN102143958A Pyridazine derivatives as SMO inhibitors |
08/03/2011 | CN102143957A Benzimidazoles and related analogs as sirtuin modulators |
08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
08/03/2011 | CN101410381B Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs) |
08/03/2011 | CN101119973B 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
08/02/2011 | US7990046 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
08/02/2011 | US7989634 Melanocortin receptor agonists |
08/02/2011 | US7989626 Modulators of cellular adhesion |
08/02/2011 | US7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use |
08/02/2011 | US7989620 Hydantoin derivatives for the treatment of obstructive airway diseases |
08/02/2011 | US7989485 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
08/02/2011 | US7989475 Substituted pyrazoles, compositions containing such compounds and methods of use |
08/02/2011 | US7989462 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
08/02/2011 | US7989460 Quinazoline derivatives as angiogenesis inhibitors |
08/02/2011 | US7989458 Pyrimidine derivatives as alk-5 inhibitors |
08/02/2011 | CA2471577C Chemical compounds |
08/02/2011 | CA2463709C N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
07/28/2011 | WO2011090911A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
07/28/2011 | WO2011090738A2 Type ii raf kinase inhibitors |
07/28/2011 | WO2011089614A1 PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM |
07/28/2011 | WO2011088877A1 Compounds for electronic devices |
07/28/2011 | WO2011022596A3 Preparation of bazedoxifene and its salts |
07/28/2011 | US20110184187 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
07/28/2011 | US20110184166 Geometric synthesis of porphyrin rods |
07/28/2011 | US20110183995 Eltoprazine for suppression of l-dopa induced dyskinesias |
07/28/2011 | US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
07/28/2011 | US20110183991 5ht7 receptor ligands and compositions comprising the same |
07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/28/2011 | US20110183980 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators |
07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
07/28/2011 | US20110183958 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
07/28/2011 | US20110183957 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
07/28/2011 | US20110183955 2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators |
07/28/2011 | US20110183952 New chemical compounds |
07/28/2011 | US20110183915 Small Molecule Cancer Treatments that cause Necrosis in Cancer Cells but do not Affect Normal Cells |
07/28/2011 | US20110182850 Organic compounds and their uses |
07/28/2011 | DE102010005697A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices |
07/28/2011 | CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
07/28/2011 | CA2784807A1 Type ii raf kinase inhibitors |
07/28/2011 | CA2783624A1 Heteroaryl compounds and uses thereof |
07/27/2011 | EP2348019A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same |
07/27/2011 | EP2346859A1 Heterocyclic jak kinase inhibitors |
07/27/2011 | EP2346858A2 Methods for preparing oxazolidinones and compositions containing them |
07/27/2011 | EP2346857A2 Compounds for the treatment of inflammatory disorders |
07/27/2011 | EP2346856A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors |
07/27/2011 | EP2346852A1 Pyrrolidin-2-ones as hdm2 ligands |
07/27/2011 | EP2346849A1 Piperazine compounds with herbicidal effect |
07/27/2011 | EP2346830A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
07/27/2011 | EP2346824A1 Novel estrogen receptor ligands |
07/27/2011 | EP2346821A1 Sphingosine-1-phosphate receptor antagonists |
07/27/2011 | EP2099769B1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
07/27/2011 | EP2061762B1 Pyrazine compounds, their use and methods of preparation |
07/27/2011 | EP2016073B1 Process for the preparation of pure irbesartan |
07/27/2011 | EP1948617B1 Pyrimidinones as casein kinase ii (ck2) modulators |
07/27/2011 | EP1945626B1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
07/27/2011 | EP1753746B1 Novel pyrrole derivatives with angiotensin ii antagonist activity |
07/27/2011 | EP1641764B1 5-membered heterocycle-based p38 kinase inhibitors |
07/27/2011 | EP1638568B1 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
07/27/2011 | EP1490355B1 Indolylmaleimide derivatives |
07/27/2011 | EP1419152B1 Hiv inhibiting pyrimidines derivatives |
07/27/2011 | CN102137858A 5-lipoxygenase-activating protein inhibitor |
07/27/2011 | CN102137857A Processes for the preparation of benzoimidazol-2-yl pyrimidine derivatives |
07/27/2011 | CN102137848A 2,4-diaminopyrimidine compound |
07/27/2011 | CN102137847A Bicyclic heterocycles as MEK kinase inhibitors |
07/27/2011 | CN102137842A Preparation of 3-pyrrole substituted 2-indolinone derivatives |
07/27/2011 | CN102134235A Preparation method of 2-oxo-1-pyrrolidine derivative |
07/27/2011 | CN102134234A Indazolyl urea compounds and preparation method and medicinal use thereof |
07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
07/27/2011 | CN102134214A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
07/26/2011 | US7985771 Furanone derivatives |
07/26/2011 | US7985765 Therapeutic substituted pyrroles |
07/26/2011 | US7985730 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
07/26/2011 | CA2603185C Propane-1,3-dione derivative or salt thereof |
07/26/2011 | CA2508412C Pesticidal 5-(acylamino) pyrazole derivatives |
07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
07/26/2011 | CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands |
07/26/2011 | CA2463615C Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
07/21/2011 | WO2011086955A1 Process for preparation of pyrimidinylpyrazole compounds |
07/21/2011 | WO2011086099A1 Novel substituted triazole derivatives as gamma secretase modulators |
07/21/2011 | WO2011086031A1 Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt |
07/21/2011 | WO2011085886A1 Pyrrolidine derivatives |
07/21/2011 | WO2011085781A1 Materials for organic electroluminescent devices |
07/21/2011 | WO2011085532A1 Conjugated chain beta-n-substituted pentamethine cyanine fluorescent dye |
07/21/2011 | WO2011028044A3 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |